Current role
Regina Graul Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Regina Graul Ph.D.
Korsana Biosciences, Inc. reported in an 8-K filed December 4, 2023 that Regina Graul Ph.D. was appointed President, effective December 1, 2023.
“On November 30, 2023, the Board of Directors of Cyclerion Therapeutics, Inc. (the "Company") unanimously elected Regina Graul Ph.D., as President of the Company, effective December 1, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Korsana Biosciences, Inc. (KRSA)
SEC 8-K
Current2023-12-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Korsana Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Jonathan Violin, Ph.D. CEO, Board Member
- Regina M. Graul CEO, Board Member
- Tomas Kiselak Chairman, Board Member
- Anjeza Gjino CFO
- Mark Vignola, Ph.D. CFO
- Peter M. Hecht CFO, Board Member
- Andrew Gottesdiener Board Member
- Andrew Gottesdiener, M.D. Board Member
- Dina Katabi Board Member
- Dina Katabi, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.